RxDoctor Payments Data

David Gooding, DO

Family Medicine · Englewood, FLNPI 1053377010

Payments from drug & device makers

$1,564in general payments, 2019–2025

Across 74 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$386
  • Amgen$181
  • AbbVie$176
  • Boston Scientific$138
  • Novo Nordisk$114
  • Johnson & Johnson$83
  • plus $486 from 18 others

What the payments were for

  • Food & beverage$1,55099%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,564 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$450,665
Medicare patients
904
Services billed
14,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban192$240,934
JardianceEmpagliflozin87$116,412
FarxigaDapagliflozin Propanediol43$67,973
XareltoRivaroxaban36$52,069
OzempicSemaglutide36$38,830
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$33,245
TrulicityDulaglutide12$31,285
Repatha SureclickEvolocumab18$28,685
ProliaDenosumab15$26,286
JanuviaSitagliptin Phosphate25$26,139
MounjaroTirzepatide14$25,920
MyrbetriqMirabegron20$21,191
Rosuvastatin Calcium1,002$13,511
Breo ElliptaFluticasone/Vilanterol22$13,425
Fluticasone-SalmeterolFluticasone Propion/Salmeterol62$12,878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort, Brilinta$39$85,11084 claims
Lilly USA, LLCTrulicity, Mounjaro$27$57,20526 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$48$53,35269 claims
Johnson & JohnsonXarelto$83$52,06936 claims
Novo NordiskOzempic$114$38,83036 claims
AmgenProlia$181$26,28615 claims
AbbVieSynthroid$176$3,57363 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Englewood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →